Loading patent
US12409218B2 · 09/09/2025
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use ribonucleic acid vaccines comprising polynucleotide molecules encoding one or more influenza antigens, such as hemagglutinin antigens.
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use ribonucleic acid vaccines comprising polynucleotide molecules encoding one or more influenza antigens, such as hemagglutinin antigens.
No articles yet — metadata is still available from the registry.
0 replies · cite patents with ^
Join the discussion
Continue with GoogleNo comments yet.
